Former Acelyrin CEO Shao-Lee Lin

Ace­lyrin's found­ing CEO steps down, com­pa­ny scraps earn­ings call

Shao-Lee Lin is step­ping down as found­ing CEO of Ace­lyrin, a Cal­i­for­nia drug de­vel­op­er that raised the largest biotech IPO in 2023 and sub­se­quent­ly ran …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.